Redeye updates on EG7 ahead of Q2-results (due 15 August) where we expect solid YoY growth driven by...
Redeye updates on Embracer ahead of Q1-results (due 14 August) where we forecast a slow start to 202...
New full year guidance for adjusted EBITDA in core businesses’ is EUR 16–20m in 2025 (previously EUR...
Avtech has announced a three-year extension to its agreement with Wizz Air, significantly expanding ...
Redeye comments on Faron’s updated data from the Phase I/II BEXMAB trial in frontline high-risk MDS,...
SRV reports its Q2 figures on 8th of August. We continue to expect volume decline for the quarter, a...
Raute reports Q2 results on Aug 12. This year will set another earnings record, while the focus now ...
Redeye updates its estimates following Freemelt’s Q2 report, which was a record quarter, both in ter...
We expect a solid Q2 and raise '25e-'26e EBIT by 1% '25e-'28e EBIT CAGR of 31% driven by senior subs...
NoHo Partners' Q2 2025 results fell short of Vara Research consensus expectations, mainly due to the...
The last of the non-core assets was divested in July.
Q2 EBITA EUR 2.5m (ABGSCe EUR 6.9m) We cut '25e-'27e adj.
Report out 22 August '25e-'26e sales cut by 19-15% on lower expected machine deliveries 3y deal sign...
Q2 pre-tax profit came in at DKK 115m, DKK 19m (20%) above our estimate.
Redeye comments on Freemelt’s Q2 results, which marked a record quarter for the company, with revenu...
Q2 sales on par with FY'24, below ABGSCe only on delivery timings Deliveries likely pushed into H2, ...
North American weakness behind yesterday's Q2 PW FY guidance cut more than feared Estimates likely d...
Den tekniska utvärderingen av Prostatypes gentest fortsätter för att få produkten inkluderad i det a...
Ahead of Relais' Q2 results, we incorporate its latest acquisitions into our estimates and adjust fo...
We lower adjusted EBIT by 13% for 2025E and 6% for 2026E-27E.